SSA
PDSB icon

Schonfeld Strategic Advisors’s PDS Biotechnology PDSB Stock Holding History

Schonfeld Strategic Advisors’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-15,400
Closed -$45.1K – 2337
2024
Q2 		$45.1K Buy
+15,400
New +$49.3K ﹤0.01% 1946
2022
Q4 		– Sell
-16,800
Closed -$50K – 2904
2022
Q3 		$50K Buy
16,800
+1,100
+7% +$4.67K ﹤0.01% 2642
2022
Q2 		$57K Buy
+15,700
New +$74.6K ﹤0.01% 2208

Other funds holding PDSB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Schonfeld Strategic Advisors's PDSB Position: Q3 2024 in Review

Schonfeld Strategic Advisors sold out of PDS Biotechnology (PDSB) in Q3 2024, closing a stake of 15,400 shares — an estimated $45.1K sold.

Schonfeld Strategic Advisors first reported a position in PDSB in Q2 2022 and held it in 3 quarters. The position peaked at $57K in Q2 2022. 57 funds tracked by Wall St. Rank hold PDSB as of Q3 2024.

  • Schonfeld Strategic Advisors reported no remaining PDS Biotechnology position as of Q3 2024 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 15,400 PDS Biotechnology shares in Q3 2024, an estimated $45.1K.
  • Schonfeld Strategic Advisors first reported a position in PDS Biotechnology in Q2 2022 and held it in 3 quarters.
  • Schonfeld Strategic Advisors's PDS Biotechnology position peaked at $57K in Q2 2022.
  • 57 funds tracked by Wall St. Rank held PDS Biotechnology as of Q3 2024.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.